经尿道等离子体双极电切术治疗前列腺增生

Transurethral plasmakinetic resection of prostate for treatment of benign prostatic hyperplasia

摘要: 目的:探讨经尿道等离子体双极电切术(plasmakinetic resection of prostate,PKRP)治疗良性前列腺增生(BPH)的安全性和疗效。方法:回顾性分析2006年2月~2007年3月经尿道等离子体双极电切治疗BPH 98例临床资料。前列腺重量30~140 g。结果:PKRP手术时间30~180 min。切除前列腺组织重量22~102 g。无经尿道电切综合征发生。术后随访2~12个月,最大尿流率由术前平均6.2 ml/s升到术后18.9 ml/s。国际前列腺症状评分由术前平均26.1分降到术后7.3分。结论:经尿道等离子体双极电切术治疗BPH具有安全性高、并发症少、疗效好的优点。

Abstract: Objective: To evaluate the safety and efficacy of transurethral plasmakinetic resection of prostate(PKRP).Methods: The data of benign prostatic hyperplasia(BPH) patients with PKRP from February 2006 to March 2007 were reviewed.The weight of the prostate was between 30 g and 140 g.Results: The operation lasted for 30 to 180 min.The resected tissues weighed 22-102 g.During the operation,no transurethral prostatic resection syndrome occurred.All patients were followed up for 2-12 months.Average maximum flow-rate increasedfrom 6.2 ml/s preoperatively to 18.9 m/s postoperatively.International prostatic symptom score(IPSS) decreased from average 26.1 preoperatively to average 7.3 postoperatively.Conclusions: PKRP is effective with high safety and less complications.